TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ACET

Adicet Bio Inc

Healthcare · Biotechnology

6.40$ -29.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ACET
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -1.6% -66.7% -238.5% – – – – – – – –
– +16.5% +46.4% -100.0% +24,340.0% +1.3% -1.0% +25.4% +67.4% +136.8% +6.1% -64.6%
– +76.5% +43.8% -89.6% +427.4% -52.6% +347.9% +137.7% +36.9% +18.3% +9.7% -35.8%
– +192.5% -6.7% -84.5% -288.7% – -4,066.0% – – -90.8% -2,292.5% –
– +12.0% -46.1% -92.9% +1,890.9% +22.1% -7.5% +1,217.8% +28.6% -73.4% -75.0% +55.5%
– +2,967.6% -89.6% -99.5% +36,395.5% +198.5% – -102.4% +500.2% -73.4% +2,571.2% –
– +13.1% +2.3% +1.7% – – – – – – – –
– -20.7% +96.4% -16.7% – – – – – -95.4% – –
– – – – – – – – – – – –
– – -111.7% – -83.0% +596.6% -99.6% +79,994.1% -82.9% -99.4% +47,064.0% -32.4%
– +15.5% -191.8% – -176.1% – +6,434.3% +155.3% -110.6% – – –
– -2.2% -67.7% -250.1% – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?